Sam Chun Dang Pharm Overview

  • Year Founded
  • 1943

Year Founded

  • Status
  • Public

  • Employees
  • 408

Employees

  • Stock Symbol
  • 000250

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $134.28
  • (As of Thursday Closing)

Sam Chun Dang Pharm General Information

Description

Samchundang Pharm Co Ltd is engaged in manufacturing, distributing, importing, and exporting pharmaceuticals in South Korea. The company offers ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as gastro intestines and vitamins.

Contact Information

Website
www.scd.co.kr
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Stock Exchange
KRX
Corporate Office
  • 351 Hyoryeong-ro
  • Seoul, Seocho-gu 06643
  • South Korea
+82 00-0000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sam Chun Dang Pharm Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$134.28 $136.53 $41.37 - $166.08 $3.12B 22.8M 1.29M -$0.32

Sam Chun Dang Pharm Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 2,398,166 1,402,044 802,118 825,509
Revenue 149,123 147,362 137,244 146,038
EBITDA 2,883 2,808 13,345 (10,780)
Net Income (7,267) (7,941) 4,518 (14,453)
Total Assets 306,035 316,620 295,186 289,027
Total Debt 39,563 41,612 60,646 43,311
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sam Chun Dang Pharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sam Chun Dang Pharm‘s full profile, request access.

Request a free trial

Sam Chun Dang Pharm Patents

Sam Chun Dang Pharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220267411-A1 Refining method of ophthalmic protein pharmaceutical Pending 08-Jul-2019 000000000
EP-3997123-A1 Refining method of ophthalmic protein pharmaceutical Pending 08-Jul-2019 000000000
EP-3997123-A4 Refining method of ophthalmic protein pharmaceutical Pending 08-Jul-2019 000000000 0
JP-2023139142-A Refining method of ophthalmic protein pharmaceuticals Pending 08-Jul-2019 000000000
ES-2902325-T3 Ophthalmic pharmaceutical composition Active 26-Apr-2017 A61K38/179
To view Sam Chun Dang Pharm’s complete patent history, request access »

Sam Chun Dang Pharm Executive Team (8)

Name Title Board Seat
In-Seok Jeon Board Member & Chief Executive Officer
Chun-In Seok President
Hyung Yoon Chief Financial Officer
Tae- Eun Jang Senior Managing Director & Head of Management Support
Seong-Ryong Oh Managing Director & Head of Sales
You’re viewing 5 of 8 executive team members. Get the full list »

Sam Chun Dang Pharm Board Members (6)

Name Representing Role Since
Dae-In Yoon Sam Chun Dang Pharm Chairman 000 0000
Hyung-Jin Yoon Sam Chun Dang Pharm Board Member 000 0000
In-Seok Jeon Sam Chun Dang Pharm Board Member & Chief Executive Officer 000 0000
Sang-Ho Shim Sam Chun Dang Pharm Board Member 000 0000
Yong-Gwan Kim Sam Chun Dang Pharm Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Sam Chun Dang Pharm Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sam Chun Dang Pharm Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
DHP Korea 27-Dec-2012 0000000000 0000 Pharmaceuticals
To view Sam Chun Dang Pharm’s complete acquisitions history, request access »

Sam Chun Dang Pharm Subsidiaries (1)

Company Name Industry Location Founded
DHP Korea Pharmaceuticals Seoul, South Korea 0000
To view Sam Chun Dang Pharm’s complete subsidiaries history, request access »

Sam Chun Dang Pharm ESG

Risk Overview

Risk Rating

Updated June, 14, 2023

42.1 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,216

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 921

Rank

00.00

Percentile

Pharmaceuticals

Subindustry

00 of 452

Rank

00.00

Percentile

To view Sam Chun Dang Pharm’s complete esg history, request access »

Sam Chun Dang Pharm FAQs

  • When was Sam Chun Dang Pharm founded?

    Sam Chun Dang Pharm was founded in 1943.

  • Who is the CEO of Sam Chun Dang Pharm?

    In-Seok Jeon is the CEO of Sam Chun Dang Pharm.

  • Where is Sam Chun Dang Pharm headquartered?

    Sam Chun Dang Pharm is headquartered in Seoul, South Korea.

  • What is the size of Sam Chun Dang Pharm?

    Sam Chun Dang Pharm has 408 total employees.

  • What industry is Sam Chun Dang Pharm in?

    Sam Chun Dang Pharm’s primary industry is Drug Discovery.

  • Is Sam Chun Dang Pharm a private or public company?

    Sam Chun Dang Pharm is a Public company.

  • What is Sam Chun Dang Pharm’s stock symbol?

    The ticker symbol for Sam Chun Dang Pharm is 000250.

  • What is the current stock price of Sam Chun Dang Pharm?

    As of 18-Jul-2024 the stock price of Sam Chun Dang Pharm is $134.28.

  • What is the current market cap of Sam Chun Dang Pharm?

    The current market capitalization of Sam Chun Dang Pharm is $3.12B.

  • What is Sam Chun Dang Pharm’s current revenue?

    The trailing twelve month revenue for Sam Chun Dang Pharm is $149M.

  • What is Sam Chun Dang Pharm’s annual earnings per share (EPS)?

    Sam Chun Dang Pharm’s EPS for 12 months was -$0.32.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »